These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27466525)

  • 1. Computational and Immunohistochemical Analyses Highlight AXL as a Potential Prognostic Marker for Ovarian Cancer Patients.
    Lozneanu L; Pinciroli P; Ciobanu DA; Carcangiu ML; Canevari S; Tomassetti A; Căruntu ID
    Anticancer Res; 2016 Aug; 36(8):4155-63. PubMed ID: 27466525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.
    Rea K; Pinciroli P; Sensi M; Alciato F; Bisaro B; Lozneanu L; Raspagliesi F; Centritto F; Cabodi S; Defilippi P; Avanzi GC; Canevari S; Tomassetti A
    Oncotarget; 2015 Oct; 6(31):30859-75. PubMed ID: 26356564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axl is a prognostic marker in oral squamous cell carcinoma.
    Lee CH; Yen CY; Liu SY; Chen CK; Chiang CF; Shiah SG; Chen PH; Shieh YS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S500-8. PubMed ID: 21842265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
    Jiang C; Zhou L; Wang H; Zhang Q; Xu Y
    Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition.
    Hua W; Zhao Y; Jin X; Yu D; He J; Xie D; Duan P
    Gynecol Oncol; 2018 Nov; 151(2):356-365. PubMed ID: 30249526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher expression of receptor tyrosine kinase Axl, and differential expression of its ligand, Gas6, predict poor survival in lung adenocarcinoma patients.
    Ishikawa M; Sonobe M; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Date H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(Suppl 3):S467-76. PubMed ID: 23242819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Expression of Vimentin and Axl in Breast Cancer.
    Tanaka K; Tokunaga E; Inoue Y; Yamashita N; Saeki H; Okano S; Kitao H; Oki E; Oda Y; Maehara Y
    Clin Breast Cancer; 2016 Dec; 16(6):520-526.e2. PubMed ID: 27506606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axl and prostasin are biomarkers for prognosis of ovarian adenocarcinoma.
    Chen PX; Li QY; Yang Z
    Ann Diagn Pathol; 2013 Oct; 17(5):425-9. PubMed ID: 23707658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic Expression of AXL Is Associated With High Risk of Postoperative Relapse of Conventional Renal Cell Carcinoma.
    Peterfi L; Bjercke T; Yusenko MV; Kovacs G; Banyai D
    Anticancer Res; 2020 Jun; 40(6):3485-3489. PubMed ID: 32487648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma.
    Hattori S; Kikuchi E; Kosaka T; Miyazaki Y; Tanaka N; Miyajima A; Mikami S; Oya M
    Ann Surg Oncol; 2016 Feb; 23(2):663-70. PubMed ID: 26350366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African women.
    Ahmed L; Nalwoga H; Arnes JB; Wabinga H; Micklem DR; Akslen LA
    APMIS; 2015 Aug; 123(8):688-96. PubMed ID: 26011102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of survivin and MMP9 expressions with prognosis and clinicopathological parameters in surface epithelial ovarian carcinomas.
    Kuşku Cabuk F; Yığıt S; Demır L; Cakalağaoğlu F; Tarhan O
    Turk Patoloji Derg; 2014; 30(1):30-7. PubMed ID: 24448704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer.
    Dunne PD; McArt DG; Blayney JK; Kalimutho M; Greer S; Wang T; Srivastava S; Ong CW; Arthur K; Loughrey M; Redmond K; Longley DB; Salto-Tellez M; Johnston PG; Van Schaeybroeck S
    Clin Cancer Res; 2014 Jan; 20(1):164-75. PubMed ID: 24170546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Expression of Cullin7 Correlates with Unfavorable Prognosis in Epithelial Ovarian Cancer Patients.
    Xi J; Zeng ST; Guo L; Feng J
    Cancer Invest; 2016; 34(3):130-6. PubMed ID: 26962950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.
    Hsieh MS; Yang PW; Wong LF; Lee JM
    Oncotarget; 2016 Jun; 7(24):36956-36970. PubMed ID: 27172793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Expression of Anaplastic Lymphoma Kinase in Ovarian Carcinoma Independent of Gene Rearrangement.
    Tang S; Yang F; Du X; Lu Y; Zhang L; Zhou X
    Int J Gynecol Pathol; 2016 Jul; 35(4):337-47. PubMed ID: 27271776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axl receptor tyrosine kinase expression in breast cancer.
    D'Alfonso TM; Hannah J; Chen Z; Liu Y; Zhou P; Shin SJ
    J Clin Pathol; 2014 Aug; 67(8):690-6. PubMed ID: 24904064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
    Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
    BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
    Seike M; Kim CH; Zou F; Noro R; Chiba M; Ishikawa A; Κunugi S; Kubota K; Gemma A
    Oncol Rep; 2017 Jun; 37(6):3261-3269. PubMed ID: 28440492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.